Save $20 off with the promo code: "20BUCKSOFF"
Refinance As Low As 5.48% - Sponsored Link
Ad - Compare Up to 4 Free Offers. Home Refinance Inquiries Only.more
Profectus BioSciences Executes an Assignment and License Agreement with Wyeth for Vaccines against HIV, HCV, HPV and HSV
BALTIMORE --(Business Wire)-- Profectus BioSciences, Inc. (Profectus) announced today that it has executed an Assignment and License Agreement with Wyeth Pharmaceuticals that provides Profectus therapeutic/prophylactic vaccine programs for Humanmore
CORRECTING and REPLACING Profectus BioSciences Executes an Assignment and License Agreement with Wyeth for Vaccines against HIV, HCV, HPV and HSV
BALTIMORE - (Business Wire) Contact phone number for Jeff Meshulam is 443-743-1107 (sted 443-543-5010). The corrected release reads: PROFECTUS BIOSCIENCES EXECUTES AN ASSIGNMENT AND LICENSE AGREEMENT WITH WYETH FOR VACCINES AGAINST HIV, HCV, HPV AND HSVmore
Gilead Sciences To Present At Rodman & Renshaw 10th Annual Healthcare Conference; Webcast At 12:00 PM
This Virtual Directory does not allow contents to be listed.more
Yongye Biotechnology to Present at Roth Capital 'China Comes to Vegas' Conference
/Xinhua-PRNewswire-FirstCall/ -- Yongye Biotechnology International, Inc. , a leading developer, producer and distributor of nutrients for plants and animals, located in the People's Republic of China, today announced that the Company will present at themore
Idenix Pharmaceuticals to Present at Deutsche Bank's 2008 Biotech Boston Confab
/PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. announced today that management will present at Deutsche Bank's 2008 Biotech Boston Confab on Tuesday, November 11th at 9:40 a.m. ET. The live and archived webcast of the presentation can be accessedmore
Aastrom Biosciences Inc announces results for first quarter of fiscal year 2009
Aastrom Biosciences Inc (NasdaqCM:ASTM), a regenerative medicine company, declared on 7 November its financial results for the first quarter of fiscal 2009, ended 30 September 2008. Total revenues generated for the quarter ended 30 September 2008 weremore
Cell Genesys Inc reports Modified Dutch Auction tender offer for a portion of outstanding 3.125% convertible senior notes
Extract not available.more
Energy Biosciences Institue named "Deal of Distinction" by tech-transfer group
Contact: Melissa Edwards, Institute for Genomic Biology at Illinois 217-333-0873 University of Illinois crop sciences professor Stephen Long is deputy director of the Energy Biosciences Institute. The landmark $500 million biofuels research partnershipmore
CORRECTING and REPLACING Profectus BioSciences Executes an Assignment and License Agreement with Wyeth for Vaccines against HIV, HCV, HPV and HSV
BALTIMORE (Business Wire) -- Contact phone number for Jeff Meshulam is 443-743-1107 (sted 443-543-5010). The corrected release reads: PROFECTUS BIOSCIENCES EXECUTES AN ASSIGNMENT AND LICENSE AGREEMENT WITH WYETH FOR VACCINES AGAINST HIV, HCV, HPV AND HSVmore
Geron Scientists and Collaborators Demonstrate TAT2 Enhances Antiviral Function of Immune Cells From HIV+ Donors
The studies show that human CD8+ T-cells from HIV-infected donors exposed to TAT2 exhibited increased telomerase activity, resulting in retardation of telomere shortening, an increase in T-cell proliferation, and enhancement of critical antiviralmore
Idenix Pharmaceuticals to Present at Deutsche Bank's 2008 Biotech Boston Confab
CAMBRIDGE, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that management will present at Deutsche Bank's 2008 Biotech Boston Confab on Tuesday, November 11th at 9:40 a.m. ET. The live and archivedmore
Evonik Industries Licenses ERGO(TM) Genomics Platform for Specialty Chemicals Optimization Research Using Microbial Genomes
Integrated Genomics, Inc., a leader in microbial genomic informatics, has licensed the ERGO„ Integrated Genomics ERGO„ Optimized for analysis of microorganisms, ERGO„ About Integrated Genomics Integrated Genomicsmore
GenomeQuest Helps University of California, Davis Researchers to Identify a New Virus from Declining Grapevines
- GenomeQuest, Inc., the leader in sequence informatics, today announced researchers at the University of California, Davis used its recently announced On-Demand Informatics Solution to process and analyze next-generation sequencing data, successfullymore
XOMA Restructures Drug Development Collaboration Including Oncology Drug Candidate HCD122
(GlobeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced the restructuring of its product development collaboration with Novartis Vaccines and Diagnostics,more
Safeguard Scientifics co-leads financing of Molecular Biometrics
Molecular Biometrics will use the money to support research and development on ViaMetrics-E, which it plans to launch in Europe, Japan and Australia next year. ViaMetrics-E is a diagnostic procedure designed to help identify the most viable embryos withmore
Generex Biotechnology Corporation's Antigen Express Subsidiary Featured in Technology Update and Value Focus Review Issued by Scimitar Equity, LLC
BOSTON, Nov. 10, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology (NasdaqCM:GNBT - News) announces that Scimitar Equity, LLC issues a review of Generex Biotechnology Corporation, entitled, ''Breaking-out the Sum of the Parts: Antigen Express' Novel Cancermore
Yongye Biotechnology to Present at Roth Capital 'China Comes to Vegas' Conference
Extract not available.more
Profectus BioSciences Executes an Assignment and License Agreement with Wyeth for Vaccines against HIV, HCV, HPV and HSV
Profectus BioSciences, Inc. (Profectus) announced today that it has executed an Assignment and License Agreement with Wyeth Pharmaceuticals that provides Profectus therapeutic/prophylactic vaccine programs for Human Immunodeficiency Virus (HIV),more
Safeguard Scientifics and Oxford Bioscience Partners Co-Lead $12 Million Series a Financing for Molecular Biometrics
(NYSE: SFE), a holding company that builds value in growth-stage technology and life sciences companies, today announced it co-led a $12 million Series A financing round with for The metabolomics company The availability of Molecular Biometrics ,more
Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated
REDWOOD CITY, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the publication of results from a study indicating that Oncotype DX(R) Recurrence Score(R) results impact the way physicians treat early-stagemore
InNexus Biotechnology announces development of new colorectal cancer drug
Extract not available.more
XOMA Restructures Drug Development Collaboration Including Oncology Drug Candidate HCD122
BERKELEY, Calif., Nov. 10, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced the restructuring of its product development collaboration with Novartis Vaccines andmore
Profectus BioSciences Executes an Assignment and License Agreement with Wyeth for Vaccines against HIV, HCV, HPV and HSV
BALTIMORE--(BUSINESS WIRE)-- Profectus BioSciences, Inc. (Profectus) announced today that it has executed an Assignment and License Agreement with Wyeth Pharmaceuticals that provides Profectus therapeutic/prophylactic vaccine programs for Humanmore
SUGEN establishes SAP enterprise support task force to aggregate worldwide
SAP and the SAP User Group Executive Network (SUGEN), a global federation of twelve SAP user groups, haa established a collaborative effort to represent the collective view of members? strategic issues. SUGEN has announced the progress of an SAPmore
GenomeQuest(TM) Helps University of California, Davis Researchers to Identify a New Virus from Declining Grapevines
GenomeQuest, Inc., the leader in sequence informatics, today announced researchers at the University of California, Davis used its recently announced On-Demand Informatics Solution to process and analyze next-generation sequencing data, successfullymore
XOMA (XOMA) Announces Restructuring of Product Development and Collaboration with Novartis
XOMA Ltd. (Nasdaq: XOMA) today announced the restructuring of its product development collaboration with Novartis Vaccines and Diagnostics, Inc. which involves six development programs including the ongoing HCD122 program. Under the restructuredmore
XOMA Restructures Drug Development Collaboration Including Oncology Drug Candidate HCD122
Extract not available.more
Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe
THOUSAND OAKS, Calif., Nov. 10 /PRNewswire/ -- Each year, hundreds of students from across the United States (U.S.) participate in the Amgen Scholars Program under renowned faculty members at the country's leading universities. Now, the same opportunitymore
Aastrom Biosciences Rallies In Pre-Market On Narrower Q1 Loss
Aastrom Biosciences (ASTM: ) climbed in pre-market trading, after the company reported a narrower first quarter loss.The stock was up 18 cents around 8:50 am ET, advancing to 72 cents. If pre-market gains hold, the stock will open at its highest levelmore
XOMA Restructures Drug Development Collaboration Including Oncology Drug Candidate HCD122
BERKELEY, Calif., Nov. 10, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (NasdaqGM:XOMA - News), a leader in the discovery and development of therapeutic antibodies, today announced the restructuring of its product development collaboration with Novartis Vaccinesmore